Announcement on Convening the 2025 Annual Performance and Cash Dividend Briefing

About this update from Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A

Announcement on Convening the 2025 Annual Performance and Cash Dividend Briefing The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A